<i>ESR1</i> Gene Mutations and Liquid Biopsy in ER-Positive Breast Cancers: A Small Step Forward, a Giant Leap for Personalization of Endocrine Therapy?

<i>ESR1</i> Gene Mutations and Liquid Biopsy in ER-Positive Breast Cancers: A Small Step Forward, a Giant Leap for Personalization of Endocrine Therapy?

The predominant forms of breast cancer (BC) are hormone receptor-positive (HR+) tumors characterized by the expression of estrogen receptors (ERs) and/or progesterone receptors (PRs). Patients with HR+ tumors can benefit from endocrine therapy (ET). Three types of ET are approved for the treatment o...

Full description

Bibliographic Details
Main Authors: Margaux Betz, Vincent Massard, Pauline Gilson, Andréa Witz, Julie Dardare, Alexandre Harlé, Jean-Louis Merlin
Format: Article
Language:English
Published: MDPI AG 2023-10-01
Series:Cancers
Subjects:
endocrine therapy
breast cancer
liquid biopsy
<i>ESR1</i> gene
Online Access:https://www.mdpi.com/2072-6694/15/21/5169

Internet

https://www.mdpi.com/2072-6694/15/21/5169

Similar Items